Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity
Lydia Kalafati,Ioannis Kourtzelis,Jonas Schulte-Schrepping,Xiaofei Li,Aikaterini Hatzioannou,Tatyana Grinenko,Eman Hagag,Anupam Sinha,Canan Has,Sevina Dietz,Antonio Miguel de Jesus Domingues,Marina Nati,Sundary Sormendi,Ales Neuwirth,Antonios Chatzigeorgiou,Athanasios Ziogas,Mathias Lesche,Andreas Dahl,Ian Henry,Pallavi Subramanian,Ben Wielockx,Peter Murray,Peter Mirtschink,Kyoung-Jin Chung,Joachim L. Schultze,Mihai G. Netea,George Hajishengallis,Panayotis Verginis,Ioannis Mitroulis,Triantafyllos Chavakis
DOI: https://doi.org/10.1016/j.cell.2020.09.058
IF: 64.5
2020-10-01
Cell
Abstract:Trained innate immunity, induced via modulation of mature myeloid cells or their bone marrow progenitors, mediates sustained increased responsiveness to secondary challenges. Here, we investigated whether anti-tumor immunity can be enhanced through induction of trained immunity. Pre-treatment of mice with β-glucan, a fungal-derived prototypical agonist of trained immunity, resulted in diminished tumor growth. The anti-tumor effect of β-glucan-induced trained immunity was associated with transcriptomic and epigenetic rewiring of granulopoiesis and neutrophil reprogramming toward an anti-tumor phenotype; this process required type I interferon signaling irrespective of adaptive immunity in the host. Adoptive transfer of neutrophils from β-glucan-trained mice to naive recipients suppressed tumor growth in the latter in a ROS-dependent manner. Moreover, the anti-tumor effect of β-glucan-induced trained granulopoiesis was transmissible by bone marrow transplantation to recipient naive mice. Our findings identify a novel and therapeutically relevant anti-tumor facet of trained immunity involving appropriate rewiring of granulopoiesis.
cell biology,biochemistry & molecular biology